<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "indomethacin inj VIAL">
<dose><value>0.2</value>
<value>0.1</value>
<value>0.25</value>
</dose><route><value>IV</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>indomethacin inj VIAL</value>
</drugname><strength><value>1 mg</value>
</strength><frequency><value>ONCE</value>
<value>Q24H  </value>
</frequency><instruction><value>POST NATAL AGE &amp;lt; 48 HOURS: INITIAL DOSE 1 of 3 DOSES. Infuse dose intravenously over 20 minutes.</value>
<value>POST NATAL AGE &amp;lt; 48 HOURS: INITIAL DOSE 1 of 3 DOSES. Infuse dose intravenously over 30 minutes.</value>
<value>POST NATAL AGE &amp;lt; 48 HOURS: 2ND OF 3 DOSES. Infuse intravenously at 12 hours after initial dose.</value>
<value>POST NATAL AGE &amp;lt; 48 HOURS: 3RD OF 3 DOSES. Infuse intravenously at 36 hours after initial dose.</value>
<value>POST NATAL AGE = 2 TO 7 DAYS: INITIAL DOSE 1 of 3 DOSES. Infuse dose intravenously over 20 minutes.</value>
<value>POST NATAL AGE = 2 TO 7 DAYS: INITIAL DOSE 1 of 3 DOSES. Infuse dose intravenously over 30 minutes.</value>
<value>POST NATAL AGE = 2 TO 7 DAYS: 2ND OF 3 DOSES. Infuse intravenously at 12 hours after initial dose.</value>
<value>POST NATAL AGE = 2 TO 7 DAYS: 3RD OF 3 DOSES. Infuse intravenously at 36 hours after initial dose.</value>
<value>POST NATAL AGE &amp;gt; 7 DAYS: INITIAL DOSE 1 of 3 DOSES. Infuse dose intravenously over 20 minutes.</value>
<value>POST NATAL AGE &amp;gt; 7 DAYS: INITIAL DOSE 1 of 3 DOSES. Infuse dose intravenously over 30 minutes.</value>
<value>POST NATAL AGE &amp;gt; 7 DAYS: 2ND OF 3 DOSES. Infuse intravenously at 12 hours after initial dose.</value>
<value>POST NATAL AGE &amp;gt; 7 DAYS: 3RD OF 3 DOSES. Infuse intravenously at 36 hours after initial dose.</value>
<value>for 3 doses starting at 6 hours of age for Patent Ductus Arteriosus Prophylaxis.</value>
<value>for 3 doses starting at 9 hours of age for Patent Ductus Arteriosus Prophylaxis.</value>
<value>for 3 doses starting at 12 hours of age for Patent Ductus Arteriosus Prophylaxis.</value>
</instruction><volume></volume><units><value>mg/kg</value>
</units><additionalnotes><value>Adjust dosing interval in patients with renal dusfunction</value>
<value>Neonates less than 27 weeks gestational age or less than 1 kg body weight recommended to receive prophylaxis.</value>
</additionalnotes><population><value>NEONATE</value>
</population><indicationprn></indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=308</value>
</backgroundinformation><prninformation></prninformation><ahsformularystatus><value>Formulary, Health Canada Special Access Programme.</value>
</ahsformularystatus><ahfsname><value>Analgesics and Antipyretics, Nonsteroidal Anti-inflammatory Agents</value>
</ahfsname><highalert></highalert><maximumprndose></maximumprndose><din><value>67386-511-51</value>
</din></drug>